MDLZ vs CL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

MDLZ

35.8
AI Score
VS
MDLZ Wins

CL

23.9
AI Score

Investment Advisor Scores

MDLZ

36score
Recommendation
SELL

CL

24score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDLZ CL Winner
Revenue 10.08B 10.69B CL
Net Income 560.00M 1.34B CL
Gross Margin 27.8% 61.0% CL
Net Margin 5.6% 12.5% CL
Operating Income 808.00M 1.98B CL
ROE 2.2% 567.4% CL
ROA 0.8% 8.0% CL
Total Assets 71.12B 16.79B MDLZ
Current Ratio 0.54 1.03 CL

Relative Price Performance (Last 90 Days)

MDLZ 1M: +2.2% · 3M: +3.9% CL 1M: +7.4% · 3M: +3.8%

Current Technical Phase

MDLZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.9 · Price: $62.42

CL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.6 · Price: $93.46

Fundamentals Snapshot

Metric MDLZ CL
Market Cap — —
Forward P/E 19.0 23.1
Trailing P/E 23.5 36.8
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.6%
Operating Margin 0.2% 0.2%
EPS 2.70 2.54
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, MDLZ is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.